NCT00111410View on ClinicalTrials.gov

Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Study Completion Date

November 30, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Anakinra (r-metHuIL-1ra)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00111410 - Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter